Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 131 INDUSTRY 72 NETWORK 16 NIH 10 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Capecitabine 9 Bevacizumab 8 tislelizumab 7 Oxaliplatin 7 Drug Therapy 7 pembrolizumab 6 Surgical Procedures, Operative 6 Cisplatin 6 Standard of Care 5 Radiotherapy 5 Laparoscopy 5 Fluorouracil 5 Docetaxel 5 Carboplatin 5 toripalimab 4 Radiosurgery 4 Leucovorin 4 Exercise 4 Epirubicin 4 Cyclophosphamide 4 pertuzumab 3 durvalumab 3 dalpiciclib 3 atezolizumab 3 anlotinib 3 Saline Solution 3 Rituximab 3 Radiation 3 Prednisone 3 Population Groups 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Irinotecan × 1 year × Clear all

NCT04776655 2025-10-02

LIBImAb

Azienda USL Reggio Emilia - IRCCS

Phase 3 Recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡